Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors
NCT07139067
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Advanced Solid Tumor Cancer
Interventions
BIOLOGICAL:
YK1101 cells
Sponsor
Peking University
Collaborators
[object Object]